Both in Pharmaceuticals
Abbott Laboratories vs ABBVIE
Over the past year ABT returned −14.1% and ABBV returned +35.2%; their daily moves had a correlation of 0.29.
ABT −14.1% ABBV +35.2%Growth of $1, one year, split-adjusted
| Metric | ABT | ABBV |
|---|---|---|
| Price | $106.20 | $294.89 |
| Market cap | $183.77B | $521.11B |
| Today | +1.56% | +1.41% |
| 1 month | +9.8% | +13.4% |
| 6 months | +18.7% | +42.7% |
| Year to date | −15.2% | +29.1% |
| 1 year | −14.7% | +31.0% |
| Revenue growth (YoY) | +13.0% | +10.2% |
| Gross margin | 57.7% | 74.7% |
| Net margin | 7.4% | 21.3% |
| P/E (TTM) | 33.9× | 82.8× |
| Price / sales | 3.9× | 8.1× |
| Net cash | -$27.00B | -$64.25B |
| Dividend yield | 2.37% | 2.35% |
| Volatility (60d) | 21.3% | 19.6% |
| Short % of float | 1.0% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).